Connolly, Mark P. http://orcid.org/0000-0002-1886-745X
Kotsopoulos, Nikos
Vermeersch, Sebastian
Patris, Julien
Cassiman, David
Funding for this research was provided by:
Alnylam Pharmaceuticals (Fiscal AHP)
Article History
Received: 24 March 2021
Accepted: 19 July 2021
First Online: 4 August 2021
Declarations
:
: This study did not involve any primary data collection and no patient level data is included in the analysis.
: Not applicable.
: There are no competing interests.